These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34848455)

  • 1. The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression.
    Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Ohtori S; Yonemoto T
    Anticancer Res; 2021 Dec; 41(12):6013-6021. PubMed ID: 34848455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
    Kinoshita H; Shimozato O; Ishii T; Kamoda H; Hagiwara Y; Tsukanishi T; Ohtori S; Yonemoto T
    Anticancer Res; 2021 Oct; 41(10):4947-4955. PubMed ID: 34593442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
    Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
    Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma.
    Baker AF; Dragovich T; Tate WR; Ramanathan RK; Roe D; Hsu CH; Kirkpatrick DL; Powis G
    J Lab Clin Med; 2006 Feb; 147(2):83-90. PubMed ID: 16459166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines.
    Wang F; Lin F; Zhang P; Ni W; Bi L; Wu J; Jiang L
    Oncol Rep; 2015 Feb; 33(2):967-73. PubMed ID: 25483731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin inhibitor PX-12 induces mitochondria-mediated apoptosis in acute lymphoblastic leukemia cells.
    Ehrenfeld V; Fulda S
    Biol Chem; 2020 Feb; 401(2):273-283. PubMed ID: 31352431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase.
    Kim YH; Coon A; Baker AF; Powis G
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):405-13. PubMed ID: 21069338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.
    Ramanathan RK; Abbruzzese J; Dragovich T; Kirkpatrick L; Guillen JM; Baker AF; Pestano LA; Green S; Von Hoff DD
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):503-9. PubMed ID: 20461382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.
    Jordan BF; Runquist M; Raghunand N; Gillies RJ; Tate WR; Powis G; Baker AF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):529-36. PubMed ID: 15701837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PX-12 induces apoptosis in Calu-6 cells in an oxidative stress-dependent manner.
    You BR; Shin HR; Han BR; Park WH
    Tumour Biol; 2015 Mar; 36(3):2087-95. PubMed ID: 25391429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).
    Liu Y; Zhao Y; Wei Z; Tao L; Sheng X; Wang S; Chen J; Ruan J; Liu Z; Cao Y; Shan Y; Wang A; Chen W; Lu Y
    Cell Physiol Biochem; 2018; 50(5):1945-1963. PubMed ID: 30396169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells.
    Haas B; Schütte L; Wos-Maganga M; Weickhardt S; Timmer M; Eckstein N
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of disulfides as anticancer agents with thioredoxin inhibition.
    Wei X; Zhong M; Wang S; Li L; Song ZL; Zhang J; Xu J; Fang J
    Bioorg Chem; 2021 May; 110():104814. PubMed ID: 33756234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.
    Ramanathan RK; Stephenson JJ; Weiss GJ; Pestano LA; Lowe A; Hiscox A; Leos RA; Martin JC; Kirkpatrick L; Richards DA
    Invest New Drugs; 2012 Aug; 30(4):1591-6. PubMed ID: 21863237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Bhatia M; Tonissen KF
    Oncotarget; 2015 Jun; 6(17):15410-24. PubMed ID: 25945832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction.
    Sadeghirizi A; Yazdanparast R; Aghazadeh S
    Tumour Biol; 2016 May; 37(5):6737-47. PubMed ID: 26662109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo.
    Lin QD; Liu LN; Liu XY; Yan Y; Fang BJ; Zhang YL; Zhou J; Li YF; Zuo WL; Song YP
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1283-1292. PubMed ID: 35253185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers.
    Baker AF; Adab KN; Raghunand N; Chow H; Stratton SP; Squire SW; Boice M; Pestano LA; Kirkpatrick DL; Dragovich T
    Invest New Drugs; 2013 Jun; 31(3):631-641. PubMed ID: 22711542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
    Welsh SJ; Williams RR; Birmingham A; Newman DJ; Kirkpatrick DL; Powis G
    Mol Cancer Ther; 2003 Mar; 2(3):235-43. PubMed ID: 12657718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.
    Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B
    Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.